Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suryadeep Chakraborty

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|April 27, 2026
A High-throughput Fluorescence Polarization Assay for Screening Sirtuin InhibitorsKewen Peng, Suryadeep Chakraborty, Yizhen Jin, et al.
Chemistry, an Asian Journal|March 23, 2022
Metalloenzymes for Fatty Acid-Derived Hydrocarbon Biosynthesis: Nature's Cryptic CatalystsTabish Iqbal, Suryadeep Chakraborty, Subhashini Murugan, et al.
ACS Chemical Biology|April 17, 2026
A High-Throughput Fluorescence Polarization Assay for Screening Sirtuin InhibitorsKewen Peng, Suryadeep Chakraborty, Yizhen Jin, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology ApproachKewen Peng, Suryadeep Chakraborty, Shamar D Wallace, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|April 27, 2026
A High-throughput Fluorescence Polarization Assay for Screening Sirtuin InhibitorsKewen Peng, Suryadeep Chakraborty, Yizhen Jin, et al.
Chemistry, an Asian Journal|March 23, 2022
Metalloenzymes for Fatty Acid-Derived Hydrocarbon Biosynthesis: Nature's Cryptic CatalystsTabish Iqbal, Suryadeep Chakraborty, Subhashini Murugan, et al.
ACS Chemical Biology|April 17, 2026
A High-Throughput Fluorescence Polarization Assay for Screening Sirtuin InhibitorsKewen Peng, Suryadeep Chakraborty, Yizhen Jin, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology ApproachKewen Peng, Suryadeep Chakraborty, Shamar D Wallace, et al.
Pageof 1